News
Immunome Publishes Preclinical Research Demonstrating that Inhibition of IL-38 Using an Antibody Leads to Anti-Tumor Activity
Relmada Therapeutics Provides Corporate Update and Reports First Quarter 2023 Financial Results
SIRPant Immunotherapeutics Announces FDA Clearance of IND Application for SIRPant-M™ Autologous SIRPαlow Activated Macrophage Immunotherapy
Annovis Bio Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
Relmada Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2022 Financial Results